• Share
  • Email
  • Print

Calvina Bostick

Partner
+1.212.536.3964
Fax +1.212.536.3901

Calvina Bostick is a partner in the firm’s New York office. Her practice focuses on mergers and acquisitions, private equity investments and other business transactions. She represents public and private operating companies, private equity firms and financial institutions in transactions across a broad range of industries, including healthcare, financial services, technology, media and insurance.
Ms. Bostick regularly advises clients in the following areas:

  • Domestic and cross-border mergers, stock and asset acquisitions and divestitures
  • Pharmaceutical product acquisitions and licenses
  • Joint ventures and strategic alliances
  • Corporate recapitalizations and reorganizations
  • Private equity and mezzanine financings
  • Commercial contracts, including development agreements, manufacturing and supply agreements and license agreements
  • General corporate and commercial matters

Achievements

  • Legal 500 Next Generation Lawyer, M&A: Middle Market ($500M-$999M), 2018
  • Network Journal Top 40 Under Forty Achievement Award, 2015

Speaking Engagements

  • Delaware Bar Association, “The Ins & Outs of Indemnification Provisions,” November 2009
  • CLE Presentation for a Fortune 500 Company, “M&A and Coordination with Business Lawyers,” June 2011
  • 8th Annual CCWC Career Strategies Conference, “Elements of M&A Transactions,” October 2012
  • 11th Annual CCWC Career Strategies Conference, “Strategies for Surviving a Merger and Acquisition,” September 2015
  • 14th Annual CCWC Career Strategies Conference, “M&A Lessons: In-house and Outside Counsel Perspective”
  • Represented Par Pharmaceutical in acquisitions of development and manufacturing companies and contract research organizations in the United States and India.
  • Represented Mayne Pharma in its acquisition of 42 generic products in an FTC-mandated divestiture related to Teva’s acquisition of Allergan’s generic pharmaceutical business
  • Represented Par Pharmaceutical in connection with pharmaceutical product acquisitions, development agreements, manufacturing and supply agreements and license agreements.
  • Represented Engine Group, a PE portfolio company, in multiple acquisitions of media companies
  • Represented London Stock Exchange Group in connection with its acquisition of a publicly traded U.S. broker-dealer.
  • Represented Willis North America in connection with its divestiture of multiple offices and insurance brokerages businesses.
  • Represented DuPont in its multi-million dollar acquisition of a global sulfuric acid firm.
  • Represented an early-stage pharmaceutical R&D company in connection with a debt financing for the construction of an R&D facility in India.
  • Represented Philips Electronics in connection with its acquisition of a U.S. remote cardiac monitoring company.
  • Represented Carrier Corporation, a leading provider of high-technology heating, air-conditioning and refrigeration solutions in a strategic joint venture with Reefer Systems, Inc. (Midlands Carrier Transicold) to provide wholesale distribution of HVAC equipment
  • Represented Crucible Materials, a specialty metals company, in connection with the sale of various groups of its assets in Chapter 11 proceedings.
  • Represented Chambers Street Properties, a public REIT in connection with its $1 billion unsecured credit facility.
  • Represented one of the world’s largest construction companies in its joint venture with a real estate development company to manufacture modular units for the construction of high-rise residential buildings.